Key result
Specific microRNAs emerge as key regulators in atrial fibrillation and associated acute ischemic stroke.
Systematic Review
Answers are grounded in this paper and cite their sources.
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression by binding to target messenger RNAs (mRNAs). miRNAs have been implicated in a variety of cardiovascular and neurological diseases, such as myocardial infarction, cardiomyopathies of various geneses, rhythmological diseases, neurodegenerative illnesses and strokes. Numerous studies have focused on the expression of miRNA patterns with respect to atrial fibrillation (AF) or acute ischemic stroke (AIS) However, only a few studies have addressed the expression pattern of miRNAs in patients with AF and AIS in order to provide not only preventive information but also to identify therapeutic potentials. Therefore, the aim of this review is to summarize 18 existing manuscripts that have dealt with this combined topic of AF and associated AIS in detail and to shed light on the most frequently mentioned miRNAs-1, -19, -21, -145 and -146 with regard to their molecular mechanisms and targets on both the heart and the brain. From this, possible diagnostic and therapeutic consequences for the future could be derived.
No takes yet. Share an insight, caveat, or question.
Boxhammer et al. (2024) conducted a systematic review in Atrial Fibrillation and Acute Ischemic Stroke. microRNAs (miRNAs-1, -19, -21, -145 and -146) was evaluated on Molecular mechanisms, targets, and diagnostic/therapeutic potential. A systematic review of 18 studies highlighted miRNAs-1, -19, -21, -145, and -146 as key molecular regulators in atrial fibrillation and associated acute ischemic stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: